These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16523333)

  • 21. Biological evaluation of both enantiomers of fluoro-thalidomide using human myeloma cell line H929 and others.
    Tokunaga E; Akiyama H; Soloshonok VA; Inoue Y; Hara H; Shibata N
    PLoS One; 2017; 12(8):e0182152. PubMed ID: 28763493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance.
    Yasui H; Hideshima T; Raje N; Roccaro AM; Shiraishi N; Kumar S; Hamasaki M; Ishitsuka K; Tai YT; Podar K; Catley L; Mitsiades CS; Richardson PG; Albert R; Brinkmann V; Chauhan D; Anderson KC
    Cancer Res; 2005 Aug; 65(16):7478-84. PubMed ID: 16103102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells.
    Agarwal B; Bhendwal S; Halmos B; Moss SF; Ramey WG; Holt PR
    Clin Cancer Res; 1999 Aug; 5(8):2223-9. PubMed ID: 10473109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BCL-X expression in multiple myeloma: possible indicator of chemoresistance.
    Tu Y; Renner S; Xu F; Fleishman A; Taylor J; Weisz J; Vescio R; Rettig M; Berenson J; Krajewski S; Reed JC; Lichtenstein A
    Cancer Res; 1998 Jan; 58(2):256-62. PubMed ID: 9443402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-mediated (TRAIL) apoptosis.
    Jazirehi AR; Ng CP; Gan XH; Schiller G; Bonavida B
    Clin Cancer Res; 2001 Dec; 7(12):3874-83. PubMed ID: 11751478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimyeloma activity of two novel N-substituted and tetraflourinated thalidomide analogs.
    Kumar S; Raje N; Hideshima T; Ishitsuka K; Roccaro A; Shiraishi N; Hamasaki M; Yasui H; Munshi NC; Richardson P; Figg WD; Anderson KC
    Leukemia; 2005 Jul; 19(7):1253-61. PubMed ID: 15858615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 protein.
    van de Donk NW; Kamphuis MM; van Dijk M; Borst HP; Bloem AC; Lokhorst HM
    Leukemia; 2003 Jan; 17(1):211-9. PubMed ID: 12529680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thalidomide for the treatment of multiple myeloma.
    Hattori Y; Iguchi T
    Congenit Anom (Kyoto); 2004 Sep; 44(3):125-36. PubMed ID: 15327481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of histone deacetylase inhibitor, depsipeptide (FR901228), effect on multiple myeloma.
    Khan SB; Maududi T; Barton K; Ayers J; Alkan S
    Br J Haematol; 2004 Apr; 125(2):156-61. PubMed ID: 15059137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. R-(-)-gossypol (AT-101) activates programmed cell death in multiple myeloma cells.
    Kline MP; Rajkumar SV; Timm MM; Kimlinger TK; Haug JL; Lust JA; Greipp PR; Kumar S
    Exp Hematol; 2008 May; 36(5):568-76. PubMed ID: 18346839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of thalidomide in the treatment of multiple myeloma].
    Mikala G; Jákó J; Vályi-Nagy I
    Orv Hetil; 2001 Aug; 142(33):1789-98. PubMed ID: 11573449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lovastatin-induced inhibition of HL-60 cell proliferation via cell cycle arrest and apoptosis.
    Park WH; Lee YY; Kim ES; Seol JG; Jung CW; Lee CC; Kim BK
    Anticancer Res; 1999; 19(4B):3133-40. PubMed ID: 10652602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment of stable multiple myeloma cell line with overexpressed PDCD5 and its proapoptosis mechanism.
    Feng W; Fu Y; Zhang Y; Lv B; Li X; Zhang F; Gui R; Liu J
    Int J Clin Exp Pathol; 2015; 8(9):10635-43. PubMed ID: 26617773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol as a novel agent for treatment of multiple myeloma with matrix metalloproteinase inhibitory activity.
    Sun CY; Hu Y; Guo T; Wang HF; Zhang XP; He WJ; Tan H
    Acta Pharmacol Sin; 2006 Nov; 27(11):1447-52. PubMed ID: 17049120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins.
    Marriott JB; Clarke IA; Czajka A; Dredge K; Childs K; Man HW; Schafer P; Govinda S; Muller GW; Stirling DI; Dalgleish AG
    Cancer Res; 2003 Feb; 63(3):593-9. PubMed ID: 12566301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Bcl-2 family protein inhibitor, ABT-737, has substantial antimyeloma activity and shows synergistic effect with dexamethasone and melphalan.
    Trudel S; Stewart AK; Li Z; Shu Y; Liang SB; Trieu Y; Reece D; Paterson J; Wang D; Wen XY
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):621-9. PubMed ID: 17255285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lenalidomide and thalidomide: mechanisms of action--similarities and differences.
    Anderson KC
    Semin Hematol; 2005 Oct; 42(4 Suppl 4):S3-8. PubMed ID: 16344099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thalidomide: chemistry, therapeutic potential and oxidative stress induced teratogenicity.
    Kumar N; Sharma U; Singh C; Singh B
    Curr Top Med Chem; 2012; 12(13):1436-55. PubMed ID: 22650376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wogonin induces apoptosis in RPMI 8226, a human myeloma cell line, by downregulating phospho-Akt and overexpressing Bax.
    Zhang M; Liu LP; Chen Y; Tian XY; Qin J; Wang D; Li Z; Mo SL
    Life Sci; 2013 Jan; 92(1):55-62. PubMed ID: 23142241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in biology and therapy of multiple myeloma.
    Barillé-Nion S; Barlogie B; Bataille R; Bergsagel PL; Epstein J; Fenton RG; Jacobson J; Kuehl WM; Shaughnessy J; Tricot G
    Hematology Am Soc Hematol Educ Program; 2003; ():248-78. PubMed ID: 14633785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.